Captopril 25 mg tablets stability assessment in different primary packing materials

Detalhes bibliográficos
Autor(a) principal: Paiva, Flávia Costa Mendes
Data de Publicação: 2017
Outros Autores: Rocha, Helvécio Vinicius Antunes
Tipo de documento: Artigo
Idioma: por
Título da fonte: Vigilância Sanitária em Debate
DOI: 10.22239/2317-269X.00945
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945
Resumo: Introduction: Packaging is used to provide protection and information, from the production to the administration of a formulation. It is essential to define the primary packaging, for keeping the therapeutic efficacy of drugs, safety of users and for protecting drugs from instability. Objectives: The main objective of this study was to assess the stability of captopril 25 mg tablets in different primary packaging materials. Method: The characterization (IR, DSC and physical tests) of the packaging materials used for captopril was carried out prior to the manufacture of tablets. Tablets were also characterized by physical-chemical analysis, comparative dissolution profile and stability studies. Results: The characterization of packaging materials was crucial for understanding the behavior of captopril when packed in each material. Materials with significant barrier, as blisters PVC/PVdC 90 g.m-² and hard aluminum and PVC/PE/PVdC and hard aluminum showed satisfactory results in a second stage, S2. On the contrary, lower barrier materials as blisters PVC/PVdC 40 g.m-² and hard aluminum did not present dissolution analysis S2. Conclusions: The aluminum strip presented the best results. And the batch in glass bottle, although packaged in excellent material, was disapproved in accelerated stability.
id FIOCRUZ-9_577b09d8574a84b911f74429c8e674da
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/945
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
spelling Captopril 25 mg tablets stability assessment in different primary packing materialsAvaliação da estabilidade de comprimidos de captopril 25 mg em distintos materiais de embalagem primáriaPackagingStabilityCaptoprilTabletsEmbalagemEstabilidadeCaptoprilComprimidosIntroduction: Packaging is used to provide protection and information, from the production to the administration of a formulation. It is essential to define the primary packaging, for keeping the therapeutic efficacy of drugs, safety of users and for protecting drugs from instability. Objectives: The main objective of this study was to assess the stability of captopril 25 mg tablets in different primary packaging materials. Method: The characterization (IR, DSC and physical tests) of the packaging materials used for captopril was carried out prior to the manufacture of tablets. Tablets were also characterized by physical-chemical analysis, comparative dissolution profile and stability studies. Results: The characterization of packaging materials was crucial for understanding the behavior of captopril when packed in each material. Materials with significant barrier, as blisters PVC/PVdC 90 g.m-² and hard aluminum and PVC/PE/PVdC and hard aluminum showed satisfactory results in a second stage, S2. On the contrary, lower barrier materials as blisters PVC/PVdC 40 g.m-² and hard aluminum did not present dissolution analysis S2. Conclusions: The aluminum strip presented the best results. And the batch in glass bottle, although packaged in excellent material, was disapproved in accelerated stability.Introdução: A embalagem farmacêutica é utilizada para prover proteção e informação, da produção à administração de uma formulação. É essencial que seja feita uma avaliação criteriosa da embalagem destinada a um medicamento, a fim de manter a eficácia terapêutica e a segurança dos usuários e de proteger o medicamento de possíveis instabilidades. Objetivo: O objetivo principal deste estudo foi avaliar a estabilidade de comprimidos de captopril 25 mg em distintos materiais de embalagem primária. Método: A caracterização (IV, DSC e testes físicos) dos materiais de embalagem utilizados para o captopril foi realizada anteriormente à fabricação dos comprimidos. Os comprimidos foram caracterizados por análise físico-química, perfil de dissolução comparativo e estudos de estabilidade. Resultados: A caracterização da embalagem foi decisiva para compreender o comportamento do captopril quando acondicionado em cada material. Materiais com barreira expressiva, como blísteres de PVC/PVdC 90 g.m-² e alumínio duro e PVC/PE/PVdC e alumínio duro demonstraram resultados satisfatórios em um segundo segundo estágio (S2), enquanto materiais de menor barreira, como blísteres de PVC/PVdC 40 g.m-² e alumínio duro, não apresentaram análise de dissolução S2. Conclusões: O lote em strip de alumínio apresentou os melhores resultados. E o lote em frasco de vidro, apesar de acondicionado em excelente material, foi reprovado na estabilidade acelerada.Instituto Nacional de Controle de Qualidade em Saúde2017-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/94510.22239/2317-269X.00945Health Surveillance under Debate: Society, Science & Technology ; Vol. 5 No. 4 (2017): November; 54-67Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 5 Núm. 4 (2017): Noviembre; 54-67Vigil Sanit Debate, Rio de Janeiro; v. 5 n. 4 (2017): Novembro; 54-672317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/422https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/487Copyright (c) 2017 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessPaiva, Flávia Costa MendesRocha, Helvécio Vinicius Antunes2023-06-27T15:01:00Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/945Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:01Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Captopril 25 mg tablets stability assessment in different primary packing materials
Avaliação da estabilidade de comprimidos de captopril 25 mg em distintos materiais de embalagem primária
title Captopril 25 mg tablets stability assessment in different primary packing materials
spellingShingle Captopril 25 mg tablets stability assessment in different primary packing materials
Captopril 25 mg tablets stability assessment in different primary packing materials
Paiva, Flávia Costa Mendes
Packaging
Stability
Captopril
Tablets
Embalagem
Estabilidade
Captopril
Comprimidos
Paiva, Flávia Costa Mendes
Packaging
Stability
Captopril
Tablets
Embalagem
Estabilidade
Captopril
Comprimidos
title_short Captopril 25 mg tablets stability assessment in different primary packing materials
title_full Captopril 25 mg tablets stability assessment in different primary packing materials
title_fullStr Captopril 25 mg tablets stability assessment in different primary packing materials
Captopril 25 mg tablets stability assessment in different primary packing materials
title_full_unstemmed Captopril 25 mg tablets stability assessment in different primary packing materials
Captopril 25 mg tablets stability assessment in different primary packing materials
title_sort Captopril 25 mg tablets stability assessment in different primary packing materials
author Paiva, Flávia Costa Mendes
author_facet Paiva, Flávia Costa Mendes
Paiva, Flávia Costa Mendes
Rocha, Helvécio Vinicius Antunes
Rocha, Helvécio Vinicius Antunes
author_role author
author2 Rocha, Helvécio Vinicius Antunes
author2_role author
dc.contributor.author.fl_str_mv Paiva, Flávia Costa Mendes
Rocha, Helvécio Vinicius Antunes
dc.subject.por.fl_str_mv Packaging
Stability
Captopril
Tablets
Embalagem
Estabilidade
Captopril
Comprimidos
topic Packaging
Stability
Captopril
Tablets
Embalagem
Estabilidade
Captopril
Comprimidos
description Introduction: Packaging is used to provide protection and information, from the production to the administration of a formulation. It is essential to define the primary packaging, for keeping the therapeutic efficacy of drugs, safety of users and for protecting drugs from instability. Objectives: The main objective of this study was to assess the stability of captopril 25 mg tablets in different primary packaging materials. Method: The characterization (IR, DSC and physical tests) of the packaging materials used for captopril was carried out prior to the manufacture of tablets. Tablets were also characterized by physical-chemical analysis, comparative dissolution profile and stability studies. Results: The characterization of packaging materials was crucial for understanding the behavior of captopril when packed in each material. Materials with significant barrier, as blisters PVC/PVdC 90 g.m-² and hard aluminum and PVC/PE/PVdC and hard aluminum showed satisfactory results in a second stage, S2. On the contrary, lower barrier materials as blisters PVC/PVdC 40 g.m-² and hard aluminum did not present dissolution analysis S2. Conclusions: The aluminum strip presented the best results. And the batch in glass bottle, although packaged in excellent material, was disapproved in accelerated stability.
publishDate 2017
dc.date.none.fl_str_mv 2017-11-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945
10.22239/2317-269X.00945
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945
identifier_str_mv 10.22239/2317-269X.00945
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/422
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/487
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; Vol. 5 No. 4 (2017): November; 54-67
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 5 Núm. 4 (2017): Noviembre; 54-67
Vigil Sanit Debate, Rio de Janeiro; v. 5 n. 4 (2017): Novembro; 54-67
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1822182070465593344
dc.identifier.doi.none.fl_str_mv 10.22239/2317-269X.00945